Clinical Trial Update: Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study [NA]

View source ↗

Summary

A clinical trial update for the Wearable Cardioverter Defibrillator in hemodialysis patients (WED-HED) has terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Arrest
• Sudden Cardiac Death

Snippet

Sponsor: Zoll Medical Corporation | Conditions: Sudden Cardiac Death, Sudden Cardiac Arrest | NA | Status: TERMINATED | Results posted: 2021-01-19